PAS
ALT icon

PKS Advisory Services’s Altimmune ALT Stock Holding History

PKS Advisory Services’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.4K Buy
+15,600
New +$46.6K 0.01% 375
2026
Q1 		– Sell
-15,100
Closed -$54.5K – 229
2025
Q4 		$54.5K Buy
+15,100
New +$65.8K 0.01% 253

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PKS Advisory Services's ALT Position: Q2 2026 in Review

PKS Advisory Services opened a new position in Altimmune (ALT) in Q2 2026: 15,600 shares worth $47.4K. The stake represents 0.01% of the portfolio and ranks #375 among its holdings. This is a return to the name: PKS Advisory Services previously reported a position in ALT as recently as Q4 2025.

PKS Advisory Services first reported a position in ALT in Q4 2025 and has held it in 2 quarters since. The position peaked at $54.5K in Q4 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • PKS Advisory Services held 15,600 shares of Altimmune worth $47.4K as of Q2 2026.
  • Altimmune was a new PKS Advisory Services position in Q2 2026.
  • Altimmune made up 0.01% of PKS Advisory Services's portfolio in Q2 2026, its #375 holding.
  • PKS Advisory Services first reported a position in Altimmune in Q4 2025 and has held it in 2 quarters since.
  • PKS Advisory Services's Altimmune position peaked at $54.5K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on PKS Advisory Services's 13F filing for Q2 2026, filed 4 Aug 2026.